SOBRE ESTE PODCAST 🔗

Apresentadores:
Frequência de atualização:
weekly
Duração média do áudio:
5 minutes
Inglês
106 episódios
desde 2 de Janeiro de 2024
episodic

ÚLTIMO EPISÓDIO 🔗

The World Health Organization (WHO) has released a guideline on the use of GLP-1 medications, which is getting lots of attention worldwide. I have some mixed feelings about what they said - find out more here! Learn more: https://drsue.ca/2025/12/what-did-the-world-health-organization-say-about-glp…

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Dishing The Science with Dr. Sue.

EPISÓDIOS ANTERIORES

GLP1-based medications have many health benefits - but based on this recent study of oral semaglutide, preventing progression of Alzheimer's doesn't seem to be one of those benefits.  Find out more about topline results here.  Learn more: https://drsue.ca/2025/11/ozempic-in-a-pill-not-eff…
While some people may be excited to lose as much weight as fast as possible with weight loss medication, there are a number of reasons why faster weight loss is NOT better weight loss. So how fast is too fast?  Find out here! Learn more: https://drsue.ca/2025/11/how-fast-is-too-fast-weight-loss-wit…
News headlines applaud weight loss medications that give the BIGGEST or FASTEST weight loss.  But is greater or faster weight loss actually better?  Learn more: https://drsue.ca/2025/11/headlines-is-faster-and-greater-weight-loss-a-good-thing/ Any medical discussion on this podcast is intended to b…
Some people don't tolerate GLP-1 medications, or need something more for weight loss.  Could amylin agonists be the next  hormone-based weight loss medications that could fill these gaps?  Learn more: https://drsue.ca/2025/11/amylin-the-next-hormone-based-weight-management-medications/ Any med…
Did you know that women with polycystic ovary syndrome, as well as women in perimenopause or menopause, are at increased risk of MASLD/MASH (formerly known as fatty liver disease)?  Find out more here! Learn more: https://drsue.ca/2025/11/what-women-need-to-know-polycystic-ovary-syndrome-perimenopa…
Why are people with obesity denied joint replacement surgery - and what is being done to fix it? Way to go Obesity Canada! Learn more: https://drsue.ca/2025/10/why-people-with-obesity-are-denied-joint-replacement-surgery-and-what-is-being-done-to-fix-it/  Any medical discussion on this podcast is i…
Online websites that prescribe weight management medication are becoming increasingly accessible and popular.  Here are some of the checkpoints to make sure you are getting the care you need and deserve.  Learn more: https://drsue.ca/2025/10/online-weight-loss-medication-are-you-getting-the-treatme…
Can GLP-1 medications cause altered skin sensations? Find out what we know here. Learn more: https://drsue.ca/2025/10/can-glp-1-medications-cause-funky-skin-sensations-dysesthesia/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audi…
Obesity expert groups around the world have created guidance documents to reframe the diagnosis and assessment of obesity, to look beyond BMI, and embracing weight-related health issues, which differ in their approaches. Today I'm talking about how we can distill these down into one very simpl…
Aviso: O podcast e a arte incorporada nesta página são de Dr. Sue Pedersen, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.